H HELIOME Trademark

Trademark Overview

On Thursday, November 19, 2015, a trademark application was filed for H HELIOME with the United States Patent and Trademark Office. The USPTO has given the H HELIOME trademark a serial number of 86825643. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2019. This trademark is owned by Heliome Biotech, Inc.. The H HELIOME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
h heliome

General Information

Serial Number86825643
Word MarkH HELIOME
Filing DateThursday, November 19, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements

Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of two curved lines in blue which form an outline of the letter "H". The word "HELIOME" is written in blue capital letters below the lines.
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 24, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHeliome Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameHeliome Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Monday, August 5, 2019ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 5, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, January 11, 2019EXTENSION 5 GRANTED
Thursday, December 27, 2018EXTENSION 5 FILED
Friday, January 11, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 27, 2018TEAS EXTENSION RECEIVED
Thursday, June 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, June 12, 2018EXTENSION 4 GRANTED
Tuesday, June 12, 2018EXTENSION 4 FILED
Tuesday, June 12, 2018TEAS EXTENSION RECEIVED
Wednesday, December 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, December 18, 2017EXTENSION 3 GRANTED
Monday, December 18, 2017EXTENSION 3 FILED
Monday, December 18, 2017TEAS EXTENSION RECEIVED
Saturday, May 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, May 25, 2017EXTENSION 2 GRANTED
Thursday, May 25, 2017EXTENSION 2 FILED
Thursday, May 25, 2017TEAS EXTENSION RECEIVED
Wednesday, November 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, November 14, 2016EXTENSION 1 GRANTED
Monday, November 14, 2016EXTENSION 1 FILED
Monday, November 14, 2016TEAS EXTENSION RECEIVED
Monday, August 8, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 5, 2016NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2016NOTICE OF PUBLICATION
Tuesday, March 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 22, 2016EXAMINER'S AMENDMENT MAILED
Monday, March 21, 2016EXAMINER'S AMENDMENT ENTERED
Monday, March 21, 2016EXAMINERS AMENDMENT -WRITTEN
Saturday, March 12, 2016ASSIGNED TO EXAMINER
Friday, December 4, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 25, 2015NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, November 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 23, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

heliome development research pharmaceutical